All Type of News
KPMA splits over president’s nomination
A controversy is quietly brewing within the Korea Pharmaceutical Manufacturers Association ahead of its next president’s nomination on the board of directors meeting on Feb. 16.
The key member of KPMA leadership te...
99 specialized hospitals to hold inauguration ceremony
The country’s 99 specialized hospitals will hold an inauguration ceremony Friday at the Seoul Press Center to establish their own hospital association.
Last November, the Ministry of Health and Welfare designated t...
‘Xalost’ ophthalmic agent goes to 17 European countries
Xalost (latanoprost) eye drop, a glaucoma drug, will be exported to 17 European countries, Taejoon Pharma announced on Monday.
Taejoon has recently received the marketing authorization for Xalost in Switzerland and...
100 billion won offered as drug rebates over 5 years
Korean drug makers have been discovered to offer nearly 100 billion won in rebates between 2006 and 2010, an antitrust regulator said Sunday.
In 2011 alone, 17 local and multinational firms were ordered to pay 14.3...
Doctors threatens to go to the Constitutional Court over illegal kickbacks
The Korean Medical Association claimed Thursday that if the government fails to prove the money and gifts doctors receive as illegal rebate through lawful procedures, they may go to the Constitutional Court to challen...
Doctors demand aspirin in convenient stores
Doctors demanded Thursday the National Assembly pass the revision law to allow convenience stores and supermarkets to sell over-the-counter medicines, such as cough drops and pain killers.
“Lawmakers are ignoring t...
Handok, Genexine to join forces in co-development of new drugs
Handok Pharmaceutical and Genexine Co., a drug development biotech, agreed to join hands to develop biobetters and biodrugs so that they can stay competitive with its foreign rivals.
The two companies signed a memo...
Daewoong, Almirall enter into licensing agreement for new COPD treatment
Daewoong Pharmaceutical said Thursday that it has signed an exclusive licensing agreement with Spain based Almirall S.A. for marketing Amirall’s Eklira (aclidinium bromide) in Korea.
Aclidinium bromide is a novel, ...
1,606 new product licenses issued in 2011
The Korea Food and Drug Administration announced Thursday that except for oriental medicines, licenses for new products totaled 1,606, a decrease of 25 percent a year earlier.
Of the licenses, prescription drugs ac...
Government to nurture innovative pharmaceutical firms
The Ministry of Health and Welfare unveiled a set of plans on Jan. 6 to nurture 12 globally competitive pharmaceutical companies by 2020. The 12 firms will develop 10 new drugs, and the country will take up 5.4 percen...
